| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 667896 | 70707 | CARBOPLATINO ACCORD 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | CARBOPLATINO ACCORD 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 15 ml | 10 mg/ml inyectable 15 ml | 45 | 1 | 34 | 1 vial de 15 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70707/70707_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70707/70707_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2011-04-13 | 1 | 1 | 1 | 2011-04-13 | 2011-04-13 | 0 | 2012-02-06 | View Edit Delete | ||||||||||||
| 667897 | 70707 | CARBOPLATINO ACCORD 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | CARBOPLATINO ACCORD 10 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 45 ml | 10 mg/ml inyectable 45 ml | 45 | 1 | 34 | 1 vial de 45 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70707/70707_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70707/70707_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2011-04-13 | 1 | 1 | 1 | 2011-04-13 | 2011-04-13 | 0 | 2012-02-06 | View Edit Delete | ||||||||||||
| 670696 | 72386 | OXALIPLATINO ACCORD 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | OXALIPLATINO ACCORD 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 10 ml | 5 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72386/72386_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72386/72386_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2010-10-01 | 1 | 1 | 1 | 2010-10-01 | 2010-10-01 | 1 | 2011-03-03 | View Edit Delete | ||||||||||||
| 670697 | 72386 | OXALIPLATINO ACCORD 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | OXALIPLATINO ACCORD 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 20 ml | 5 mg/ml inyectable 20 ml | 45 | 1 | 34 | 1 vial de 20 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72386/72386_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72386/72386_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11104 | ACCORD HEALTHCARE S.L.U. | 2010-10-01 | 1 | 1 | 1 | 2010-10-01 | 2010-10-01 | 1 | 2011-03-03 | View Edit Delete | ||||||||||||
| 665787 | 08479001 | ZYPADHERA 210 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA | ZYPADHERA 210 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA, 1 vial + 1 vial de disolvente | 210 mg | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08479001/08479001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08479001/08479001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44757 | LABORATORIOS RUBIO S.A. | 2010-06-09 | 1 | 1 | 1 | 2010-06-09 | 2010-06-09 | 1 | 2011-02-23 | View Edit Delete | ||||||||||||
| 665788 | 08479002 | ZYPADHERA 300 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA | ZYPADHERA 300 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA, 1 vial + 1 vial de disolvente | 300 mg | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08479002/08479002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08479002/08479002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44757 | LABORATORIOS RUBIO S.A. | 2010-06-09 | 1 | 1 | 1 | 2010-06-09 | 2010-06-09 | 1 | 2011-02-23 | View Edit Delete | ||||||||||||
| 665789 | 08479003 | ZYPADHERA 405 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA | ZYPADHERA 405 mg POLVO Y DISOLVENTE PARA SUSPENSION INYECTABLE DE LIBERACION PROLONGADA, 1 vial + 1 vial de disolvente | 405 mg | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/08479003/08479003_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/08479003/08479003_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 44757 | LABORATORIOS RUBIO S.A. | 2010-06-09 | 1 | 1 | 1 | 2010-06-09 | 2010-06-09 | 1 | 2011-02-23 | View Edit Delete | ||||||||||||
| 665906 | 07420002 | CYANOKIT 5 g POLVO PARA SOLUCION PARA PERFUSION | CYANOKIT 5 g POLVO PARA SOLUCION PARA PERFUSION, 1 vial | 5.000 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07420002/07420002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07420002/07420002_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16769 | LABORATORIOS RUBIO S.A. | 2010-11-19 | 1 | 1 | 1 | 2010-11-19 | 2010-11-19 | 0 | 2012-01-04 | View Edit Delete | ||||||||||||
| 671428 | 72466 | OCTANINE 100 UI/ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | OCTANINE 100 UI/ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE , 1 vial + 1 vial de disolvente | 1.000 UI | 45 | 1 | 34 | 1 vial + 1 vial de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72466/72466_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72466/72466_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 5237 | OCTAPHARMA S.A. | 2010-12-30 | 1 | 1 | 1 | 2010-12-30 | 2010-12-30 | 1 | 2011-09-26 | View Edit Delete | ||||||||||||
| 667348 | 70763 | EPIRUBICINA TEVA 2 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFG | EPIRUBICINA TEVA 2 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial de 25 ml | 2 mg/ml inyectable 25 ml | 45 | 1 | 34 | 1 vial de 25 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70763/70763_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70763/70763_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2010-04-05 | 1 | 1 | 1 | 2010-04-05 | 2010-04-05 | 1 | 2011-09-26 | View Edit Delete | ||||||||||||
| 667350 | 70763 | EPIRUBICINA TEVA 2 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFG | EPIRUBICINA TEVA 2 mg/ml SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial de 100 ml | 2 mg/ml inyectable 100 ml | 45 | 1 | 34 | 1 vial de 100 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70763/70763_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70763/70763_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34492 | TEVA PHARMA S.L.U. | 2010-04-05 | 1 | 1 | 1 | 2010-04-05 | 2010-04-05 | 1 | 2011-09-26 | View Edit Delete | ||||||||||||
| 667711 | 70704 | PACLITAXEL KABI 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | PACLITAXEL KABI 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 5 ml | 6 mg/ml inyectable 5 ml | 45 | 1 | 34 | 1 vial de 5 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70704/70704_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70704/70704_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2010-10-15 | 1 | 1 | 1 | 2010-10-15 | 2010-10-15 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 667712 | 70704 | PACLITAXEL KABI 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | PACLITAXEL KABI 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 16,7 ml | 6 mg/ml inyectable 16,7 ml | 45 | 1 | 34 | 1 vial de 16,7 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70704/70704_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70704/70704_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2010-10-15 | 1 | 1 | 1 | 2010-10-15 | 2010-10-15 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 667713 | 70704 | PACLITAXEL KABI 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | PACLITAXEL KABI 6 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG , 1 vial de 50 ml | 6 mg/ml inyectable 50 ml | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70704/70704_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70704/70704_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2010-10-15 | 1 | 1 | 1 | 2010-10-15 | 2010-10-15 | 1 | 2011-02-09 | View Edit Delete | ||||||||||||
| 669790 | 71346 | OXALIPLATINO KABI 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | OXALIPLATINO KABI 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 10 ml | 5 mg/ml inyectable 10 ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71346/71346_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71346/71346_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2011-04-06 | 1 | 1 | 1 | 2011-04-06 | 2011-04-06 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 669791 | 71346 | OXALIPLATINO KABI 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | OXALIPLATINO KABI 5 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 1 vial de 20 ml | 5 mg/ml inyectable 20 ml | 45 | 1 | 34 | 1 vial de 20 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/71346/71346_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/71346/71346_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 2011-04-06 | 1 | 1 | 1 | 2011-04-06 | 2011-04-06 | 1 | 2011-10-21 | View Edit Delete | ||||||||||||
| 670615 | 72377 | BOTOX 200 UNIDADES ALLERGAN, POLVO PARA SOLUCIÓN INYECTABLE | BOTOX 200 UNIDADES ALLERGAN, POLVO PARA SOLUCIÓN INYECTABLE , 1 vial | 200 U | 45 | 1 | 34 | 1 vial | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72377/72377_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72377/72377_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16052 | ABBVIE SPAIN, S.L.U. | 2011-04-08 | 1 | 1 | 1 | 2011-04-08 | 2011-04-08 | 1 | 2018-02-14 | View Edit Delete | ||||||||||||
| 668822 | 61671 | VARILRIX POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA | VARILRIX POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE EN JERINGA PRECARGADA, 1 vial + 1 jeringa precargada + 2 agujas | N/A (vacuna) | 45 | 1 | 34 | 1 vial + 1 jeringa precargada + 2 agujas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61671/61671_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61671/61671_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 1997-12-01 | 1 | 1 | 1 | 1997-12-01 | 1997-12-01 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 667541 | 70642 | ZOMACTON 10 mg/ ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | ZOMACTON 10 mg/ ml POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 1 vial + 1 jeringa precargada de disolvente | 10 mg | 45 | 1 | 34 | 1 vial + 1 jeringa precargada de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70642/70642_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70642/70642_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 31840 | FERRING S.A.U. | 2010-03-23 | 1 | 1 | 1 | 2010-03-23 | 2010-03-23 | 1 | 2011-06-28 | View Edit Delete | ||||||||||||
| 667659 | 61732 | ADENOSCAN 30 mg/10 ml SOLUCION PARA PERFUSION | ADENOSCAN 30 mg/10 ml SOLUCION PARA PERFUSION , 6 viales de 10 ml | 30 mg | 45 | 6 | 34 | 6 viales de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61732/61732_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61732/61732_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 40842 | SANOFI AVENTIS S.A. | 1998-04-01 | 1 | 1 | 1 | 1998-04-01 | 1998-04-01 | 1 | 2011-06-09 | View Edit Delete |
Page 245 of 1036, showing 20 records out of 20704 total, starting on record 4881, ending on 4900